Search hospitals > Wisconsin > Waukesha

ProHealth Care Inc

Claim this profile
Waukesha, Wisconsin 53188
Conducts research for Lymphoma
Conducts research for Non-Hodgkin's Lymphoma
Conducts research for Follicular Lymphoma
Conducts research for Leukemia
Conducts research for Myeloid Leukemia
5 reported clinical trials
1 medical researcher
Photo of ProHealth Care Inc in WaukeshaPhoto of ProHealth Care Inc in WaukeshaPhoto of ProHealth Care Inc in Waukesha

Summary

ProHealth Care Inc is a medical facility located in Waukesha, Wisconsin. This center is recognized for care of Lymphoma, Non-Hodgkin's Lymphoma, Follicular Lymphoma, Leukemia, Myeloid Leukemia and other specialties. ProHealth Care Inc is involved with conducting 5 clinical trials across 8 conditions. There are 1 research doctors associated with this hospital, such as Timothy Wassenaar, MD.

Area of expertise

1Lymphoma
ProHealth Care Inc has run 4 trials for Lymphoma. Some of their research focus areas include:
CD20 positive
Stage II
Stage III
2Non-Hodgkin's Lymphoma
ProHealth Care Inc has run 2 trials for Non-Hodgkin's Lymphoma. Some of their research focus areas include:
CD20 positive

Top PIs

Clinical Trials running at ProHealth Care Inc

Follicular Lymphoma
Lymphoma
B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Image of trial facility.

Odronextamab + Chemotherapy

for Follicular Lymphoma

This trial is testing a new drug called odronextamab combined with chemotherapy for people with a type of blood cancer called follicular lymphoma. It aims to find out how safe and effective this combination is, especially for those who haven't been treated before or whose cancer came back or didn't respond to previous treatments. The study will also compare this new treatment to the current standard treatment and look at side effects and quality of life.
Recruiting2 awards Phase 37 criteria
Image of trial facility.

Odronextamab vs Chemotherapy

for Follicular Lymphoma

This study is researching an experimental drug called odronextamab, referred to as study drug. The study is focused on participants with previously untreated follicular lymphoma (a type of non-Hodgkin lymphoma or NHL). This study will be made up of two parts: Part 1 (non-randomized) and Part 2 (randomized - controlled). The aim of Part 1 of the study is to see how safe and tolerable the study drug is when given alone. The aim of Part 2 of the study is to see how the study drug works compared to rituximab (called the "comparator drug") and chemotherapy (the current standard of care for NHL). Standard of care means the usual medication expected and used when receiving treatment for a condition. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is in the blood at different times * Whether the body makes antibodies against the study drug (which could make the study drug less effective or could lead to side effects) * How the study drug affects quality of life and ability to complete routine daily activities.
Recruiting2 awards Phase 35 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at ProHealth Care Inc?
ProHealth Care Inc is a medical facility located in Waukesha, Wisconsin. This center is recognized for care of Lymphoma, Non-Hodgkin's Lymphoma, Follicular Lymphoma, Leukemia, Myeloid Leukemia and other specialties. ProHealth Care Inc is involved with conducting 5 clinical trials across 8 conditions. There are 1 research doctors associated with this hospital, such as Timothy Wassenaar, MD.